NOTE REPURCHASE
AGREEMENT
THIS NOTE REPURCHASE AGREEMENT
(this “ Agreement
”) to repurchase VaxGen, Inc. 5 1 / 2
% Convertible Senior Subordinated
Notes Due April 1, 2010 is made as of October 27, 2008,
by and between Drawbridge Special Opportunities Fund LP , a
Delaware limited partnership (“ Holder ”), on
the one hand, and VaxGen, Inc. , a Delaware corporation
(“ Company ”), on the other hand.
WHEREAS, the Holder is the owner and holder of
that certain 5 1 / 2
% Convertible Senior Subordinated
Note Due April 1, 2010 (the “ Note ”)
identified on Schedule A hereto, issued under an
Indenture, dated as of April 5, 2005 (the “
Indenture ”), between the Company and U.S. Bank
National Association, as trustee (the “ Trustee
”);
WHEREAS, the
Note, to date, has not matured; and
WHEREAS, the Holder desires to sell the Note,
and the Company in turn desires to repurchase the Note.
NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which is hereby
acknowledged, the Holder and the Company hereby agree as
follows:
1. Sale of Note . Subject to the
terms and conditions of this Agreement, the Company agrees to
purchase from the Holder, and the Holder agrees to sell to the
Company, the Note identified on Schedule A
hereto, in the principal amount and for an aggregate purchase price
set forth on Schedule A hereto. The purchase and
sale of the Note shall take place at the offices of Cooley Godward
Kronish, 3175 Hanover Street, Palo Alto, California 94304 at 10:00
A.M. (local time), on October 28, 2008 (which time and place
are designated as the “ Closing ” and the date
thereof the “ Settlement Date ”). At the
Closing, the Holder shall deliver to the Company the Note, duly
endorsed or accompanied by an assignment duly endorsed and in a
form acceptable to the Trustee, against payment of the aggregate
purchase price described on Schedule A hereto
(the “ Purchase Price ”), by wire transfer in
the amounts and using the wire transfer instructions to be provided
separately to the Company by Holder. Upon receipt by the Holder of
the Purchase Price, the Company shall become the legal and
beneficial owner of the Note and of all rights and interest therein
or related thereto and to the monies due and to become due under
the terms of the Note. The Holder hereby agrees that upon receipt
of the Purchase Price, the Note shall be cancelled and the Company
shall have no further obligation to the Holder
thereunder.
2. Representations and Warranties of
the Holder . The Holder hereby represents and warrants to the
Company with respect to the Note issued to the Holder
that:
2.1 Ownership of Note . The Holder has,
and at the Closing will have, good and valid right, title and
interest (legal and beneficial) in and to the Note, free and clear
of all liens, pledges, security interests, charges, contractual
obligations, claims or encumbrances of any kind. Upon payment for
the Note in accordance with this Agreement, the Holder will convey
the Note to the Company free and clear of all liens, pledges,
security interests, charges, contractual obligations, claims or
encumbrances of any kind.
2.2 Organization; Authorization . The
Holder has full power and authority to enter into this Agreement.
The execution, delivery and performance by the Holder of this
Agreement has been duly authorized by all requisite action by the
Holder, and this Agreement constitutes a valid and binding
obligation of the Holder, enforceable against the Holder in
accordance with its terms, except as enforcement may be limited by
principles of equity and by bankruptcy, insolvency, reorganization,
moratorium and similar laws relating to, limiting or affecting
creditors’ rights and remedies generally.
2.3 No Consent Required . No consent,
authorization, approval, order, license, certificate or permit or
act of or from, or declaration or filing with, any foreign,
federal, state, local or other governmental authority or regulatory
body or any court or other tribunal or any party to any contract,
agreement, instrument, lease or license to which the Holder is a
party, is required for the execution, delivery or performance by
the Holder of this Agreement or any of the other agreements,
instruments and documents being or to be executed and delivered
hereunder or in connection herewith or for the consummation of the
transactions contemplated hereby.
2.4 Disclosure of Information . The
Holder has received all the information it considers necessary or
appropriate to determine whether to sell the Note to the Company
pursuant to this Agreement. The Holder acknowledges (i) the
Company has not made any representation or warranty, express or
implied, except as set forth herein, regarding any aspect of the
sale and purchase of the Note, the operation or financial condition
of the Company or the value of the Note, (ii) that it is not
relying upon the Company in making its decision to sell the Note to
the Company pursuant to this Agreement and (iii) that the
Company is relying upon the truth of the representations and
warranties in this Section 2 in connection with the purchase
of the Note hereunder.
2.5 Tax Consequences . The Holder has had
an opportunity to review the federal, state and local tax
consequences of the sale of the Note to the Company and the
transactions contemplated by this Agreement with its own tax
advisors. The Holder is relying solely on such advisors and not on
any statements or representations of the Company.
-2-
2.6 No Conflict . Neither the execution
and delivery of this Agreement, nor the consummation of any of the
transactions contemplated hereby, nor compliance with or
fulfillment of the terms, conditions and provisions hereof or
thereof will conflict with, result in a breach of the terms,
conditions or provisions of, or constitute a default (with or
without notice or lapse of time, or both), or an event creating
rights of acceleration, termination or cancellation or a loss of
rights under (i) any material note, instrument,
agree
|